# FDA Inspection 1169363 - Vitalant - April 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/2dc4bdf9-1702-4179-a2e8-757d66469a7f
Source feed: FDA_Inspections

> FDA Inspection 1169363 for Vitalant on April 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169363
- Company Name: Vitalant
- Inspection Date: 2022-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169363 - 2022-04-22](https://www.keypedia.com/records/fda_inspections/vitalant/d071ab39-8866-4582-a64b-60cc739fb149)
- [FDA Inspection 1054423 - 2018-05-24](https://www.keypedia.com/records/fda_inspections/vitalant/645ba939-8cea-41a4-9f70-f9a8509db1f0)
- [FDA Inspection 968492 - 2016-03-11](https://www.keypedia.com/records/fda_inspections/vitalant/ec8b4584-d87b-485f-96d5-f719a570003b)
- [FDA Inspection 860331 - 2013-12-19](https://www.keypedia.com/records/fda_inspections/vitalant/29cb763a-90c0-4d79-9d13-4ea843b66d9f)

Company: https://www.keypedia.com/companies/vitalant/0c14b2c7-8759-4a77-9c72-cd5b3efcd0c8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d